Hanmi Pharmaceutical announced on the 8th that it has been newly included in the 2024 Dow Jones Sustainability Index (DJSI) Korea Index, recognized for its environmental, social, and governance (ESG) management performance.
The DJSI is a sustainability assessment index published annually by S&P Global, the world's largest financial information provider. It is recognized globally for comprehensively evaluating not only the economic performance of corporations but also ESG factors. It is widely used as a criterion to assist investors in their responsible investment decision-making.
Only corporations that are rated within the top 30% of the 200 largest stocks by market capitalization in Korea can be included in the DJSI Korea Index. Hanmi Pharmaceutical was included for the first time this time, having received excellent evaluations in areas such as environmental policy and climate strategy, quality management, industrial health and safety, and business ethics.
Park Jae-hyun, CEO of Hanmi Pharmaceutical, said regarding the inclusion in the DJSI Korea Index, "This is the fruit of our company's efforts for sustainable management," and added, "We will continue to strengthen communication with various stakeholders and faithfully fulfill the corporation's social role and responsibilities to further enhance corporate value."